// Press Release

January 16th, 2020

Treatment of Metastatic Cutaneous Squamous Cell Carcinoma

Libtayo™ (cemiplimab) Receives Positive Recommendation from the pan-Canadian Oncology Drug Review Expert Review Committee for the Treatment of Metastatic Cutaneous Squamous Cell Carcinoma Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer accounting for approximately 20% of all skin cancer cases in Canada.1 OAKVILLE, ON, Jan. 16, 2020 /CNW Telbec/ – … Continue reading Treatment of Metastatic Cutaneous Squamous Cell Carcinoma

January 16th, 2020

New Journal from Elizz.com is a Game Changer in Wellness: Promoting the Perfect Path to Self-Care for a “New You” in 2020

New Journal from Elizz.com is a Game Changer in Wellness: Promoting the Perfect Path to Self-Care for a “New You” in 2020 Elizz journal helps “busy” daughters and sons of aging parents to focus on what really matters TORONTO, Jan. 14, 2020 /CNW/ – Elizz.com is changing the game for busy, family caregivers in 2020. On the scoreboard:  kickstarting … Continue reading New Journal from Elizz.com is a Game Changer in Wellness: Promoting the Perfect Path to Self-Care for a “New You” in 2020

January 16th, 2020

New App Designed to Support Mental Health and Well-Being Launches Kickstarter Campaign

New App Designed to Support Mental Health and Well-Being Launches Kickstarter Campaign Illumu helps people through their most challenging times through engaging interaction on their smartphones. A life-changing new app called Illumu has launched a Kickstarter campaign. The app is designed to help people to maintain their emotional health through their most challenging times. Illumu … Continue reading New App Designed to Support Mental Health and Well-Being Launches Kickstarter Campaign

January 16th, 2020

First Biologic Treatment for Deadly Type of Skin Cancer Gets Strong Positive Recommendation to be Covered by Provincial Health Care

First Biologic Treatment for Deadly Type of Skin Cancer Gets Strong Positive Recommendation to be Covered by Provincial Health Care Save Your Skin Foundation Applauds the pan-Canadian Oncology Drug Review recommendation for Provincial Reimbursement of LibtayoTM, the first and only biologic for the treatment of Advanced Cutaneous Squamous Cell Carcinoma TORONTO, Jan. 15, 2020 /CNW/ – Save … Continue reading First Biologic Treatment for Deadly Type of Skin Cancer Gets Strong Positive Recommendation to be Covered by Provincial Health Care

January 14th, 2020

Stanford Inn and Resort Offers Personalized Family Workshops to Help Overcome Picky Eatin

Stanford Inn and Resort Offers Personalized Family Workshops to Help Overcome Picky Eating   At this plant-based Mendocino resort children and parents cook together, learn nutrition as a team, and participate in family art and creativity workshops to build long-term healthy living habits MENDOCINO, CA _ The Stanford Inn and Resort, is offering families a chance to grab … Continue reading Stanford Inn and Resort Offers Personalized Family Workshops to Help Overcome Picky Eatin

January 14th, 2020

Best Couple Health and Fitness Escapes for Valentine’s Day

Best Couple Health and Fitness Escapes for Valentine’s Day With Valentine’s Day approaching, rediscover romance with the best Valentine’s Day wellness breaks to suit every couple. From adventure-loving, Globetrotting and sporty couples to those looking to rediscover their zen this Valentine’s Day, Health and Fitness Travel, the wellness holiday specialists has hand-picked the best health and … Continue reading Best Couple Health and Fitness Escapes for Valentine’s Day

January 14th, 2020

Health Canada Approves Astellas’ XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Health Canada Approves Astellas’ XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation XOSPATA is the first and only targeted treatment approved by Health Canada for patients with relapsed or refractory Acute Myeloid Leukemia with a FLT3 mutation. The approval of XOSPATA marks Astellas’ Canadian entry into the treatment of blood … Continue reading Health Canada Approves Astellas’ XOSPATA® (gilteritinib) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

January 14th, 2020

AbbVie’s MAVIRET® now listed on the Newfoundland and Labrador formulary

AbbVie’s MAVIRET® now listed on the Newfoundland and Labrador formulary MAVIRET® is an 8-week, pan-genotypic treatment for adults and adolescent patients 12 to 18 years of age with chronic hepatitis C virus (HCV) infection without cirrhosis and who are new to treatment.*1 MAVIRET is approved for use in patients across all stages of chronic kidney … Continue reading AbbVie’s MAVIRET® now listed on the Newfoundland and Labrador formulary

January 14th, 2020

New Year’s Thoughts from a ‘Boomer’ Doc

New Year’s Thoughts from a ‘Boomer’ Doc by Jane M. Orient, M.D. The words of the year as 2019 ends appear to be “OK Boomer” and “woke.” To this Boomer, it appears that the younger generation is blaming us for all the Evil in the world, from their perch of “woke” moral superiority. They consider … Continue reading New Year’s Thoughts from a ‘Boomer’ Doc

January 14th, 2020

First year of the Montreal Heart Institute’s Diabetes Prevention Clinic supported by Sun Life Financial

First year of the Montreal Heart Institute’s Diabetes Prevention Clinic supported by Sun Life Financial Patients on the road to recovery from type 2 diabetes MONTREAL, Jan. 13, 2020 /CNW/ – What if you were told you could reverse the course of type 2 diabetes through exercise and a healthy diet? That was the challenge … Continue reading First year of the Montreal Heart Institute’s Diabetes Prevention Clinic supported by Sun Life Financial

TRAIN IT RIGHT NEWSLETTER

Sign Up and get a free 7 day Train it Right HIIT Program!

Top